Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000184326 | SCV000236951 | pathogenic | not provided | 2013-10-08 | criteria provided, single submitter | clinical testing | c.66716delT: p.Leu22239Stop in exon 276 in the TTN gene (NM_001256850.1). The normal sequence with the bases that are deleted in braces is: GCTT{T}AGTA. The c.66716delT mutation in the TTN gene has not been reported previously as a disease-causing mutation or as a benign polymorphism, to our knowledge. c.66716delT causes a shift in reading frame starting at codon Leucine 22239, changing it to a premature stop codon, denoted p.Leu22239Stop. This mutation is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other truncating TTN variants have been reported in approximately 3% of control alleles (Herman D et al., 2012). However, c.66716delT is located in the A-band region of titin, where the majority of truncating mutations associated with DCM have been reported (Herman D et al., 2012). We interpret c.66716delT as a disease-causing mutation. The variant is found in DCM-CRDM panel(s). |